References
- PayneJFHubbardGBIIIAabergTMSrYanJClinical characteristics of hydroxychloroquine retinopathyBr J Ophthalmol201195224525020693556
- WolfeFMarmorMFRates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosusArthritis Care Res (Hoboken)201062677578420535788
- LevyGDMunzSJPaschalJCohenHBPrinceKJPetersonTIncidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practiceArthritis Rheum1997408148214869259429
- BrowningDJHydroxychloroquine and Chloroquine Retinopathy: Screening for Drug ToxicityAm J Ophthalmol2002133564965611992862
- MarmorMFComparison of screening procedures in hydroxychloroquine toxicityArch Ophthalmol2012130446146922159170
- BrowningDJImpact of the revised American academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practiceAm J Ophthalmol2013155341842823218706
- WalvickMDWalvickMPTongsonENgoCHHydroxychloroquine: lean body weight dosingOphthalmology201111810210021968180
- MichaelidesMStoverNBFrancisPJWeleberRGRetinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapyArch Ophthalmol20111291303921220626
- MackenzieAHDose refinements in long-term therapy of rheumatoid arthritis with antimalarialsAm J Med1983751A40456869410
- BrowningDJReply to Defining Ideal Body WeightAm J Ophthalmol2002134693593612470778
- BernsteinHNOcular safety of hydroxychloroquine sulfate (Plaquenil)South Med J19928532742791546352
- PaiMPPaloucekFPThe origin of the “Ideal” body weight equationsAnn Pharmacother20003491066106910981254
- YamJCKwokAKOcular toxicity of hydroxychloroquineHong Kong Med J200612429430416912357
- SundelinSPTermanADifferent effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cellsAPMIS2002110648148912193209
- JohnsonMWVineAKHydroxychloroquine therapy in massive total doses without retinal toxicityAm J Ophthalmol198710421391443618711
- BergholzRSchroeterJRutherKEvaluation of risk factors for retinal damage due to chloroquine and hydroxychloroquineBr J Ophthalmol201094121637164220940312
- NowaczykPMurawaDPolomKAnalysis of sentinel lymph node biopsy results in colon cancer in regard of the anthropometric features of the population and body composition assessment formulasLangenbecks Arch Surg2012397577978622415154
- ShahBSucherKHollenbeckCBComparison of ideal body weight equations and published height-weight tables with body mass index tables for healthy adults in the United StatesNutr Clin Pract200621331231916772549
- SchwartzSGMielerWFRetinal and Choroidal Manifestations of Systemic MedicationsArevaloJFRetinal and Choroidal Manifestations of Selected Systemic DiseasesNew YorkSpringer2013479492
- FungAESamyCNRosenfeldPJOptical coherence tomography findings in hydroxychloroquine and chloroquine-associated maculopathyRetinal Cases and Brief Reports200713128130
- MarmorMFCarrREEasterbrookMRecommendations on screening for chloroquine and hydroxychloroquine retinopathyOphthalmology200210971377138212093666
- StepienKEHanDPSchellJGodaraPRhaJCarrollJSpectral-domain optical coherence tomography and adaptive optics may detect hydroxychloroquine retinal toxicity before symptomatic vision lossTrans Am Ophthalmol Soc2009107283420126479
- ElderMRahmanAMMcLayJEarly paracentral visual field loss in patients taking hydroxychloroquineArch Ophthalmol2006124121729173317159032
- MavrikakisISfikakisPPMavrikakisEThe incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine – a reappraisalOphthalmology200311071321132612867385
- MavrikakisMPapazoglouSSfikakisPPVaiopoulosGRougasKRetinal toxicity in long term hydroxychloroquine treatmentAnn Rheum Dis19965531871898712882
- AndersonCBlahaGRMarxJLHumphrey visual field findings in hydroxychloroquine toxicityEye (Lond)201125121535154522094300
- ThorneJEMaguireAMRetinopathy after long term, standard doses of hydroxychloroquineBr J Ophthalmol199983101201120210636653
- TeohSCLimJKohALimTFuEAbnormalities on the multifocal electroretinogram may precede clinical signs of hydroxychloroquine retinotoxicityEye (Lond)200620112913215731769
- AndersonCPahkPBlahaGRPreferential hyperacuity perimetry to detect hydroxychloroquine retinal toxicityRetina20092981188119219491724
- FalconePMPaoliniLLouPLHydroxychloroquine toxicity despite normal dose therapyAnn Ophthalmol199325103853888304691
- BienfangDCoblynJSLiangMHCorzilliusMHydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive seriesJ Rheumatol200027112703270611093457
- WarnerAEEarly hydroxychloroquine macular toxicityArthritis Rheum20014481959196111508449
- WeinerASandbergMAGaudioARKiniMMBersonELHydroxychloroquine retinopathyAm J Ophthalmol199111255285341951589
- KellnerSWeinitzSKellnerUSpectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescenceBr J Ophthalmol200993111444144719692385
- KellnerURennerABTillackHFundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquineInvest Ophthalmol Vis Sci20064783531353816877425
- ChenEBrownDMBenzMSSpectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the “flying saucer” sign)Clin Ophthalmol201041151115821060664
- Rodriguez-PadillaJAHedgesTRIIIMonsonBHigh-speed ultrahigh-resolution optical coherence tomography findings in hydroxychloroquine retinopathyArch Ophthalmol2007125677578017562988
- KelmensonATBrarVSMurthyRKChalamKVFundus autofluorescence and spectral domain optical coherence tomography in early detection of Plaquenil maculopathyEur J Ophthalmology2010204785788
- ReedHKarlinskyWDelayed onset of chloroquine retinopathyCan Med Assoc J19679723140814116060846
- MarmorMFKellnerULaiTYYLyonsJSMielerWFAmerican Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathyOphthalmology2011118241542221292109
- BernsteinHNOphthalmologic considerations and testing in patients receiving long-term antimalarial therapyAm J Med1983751A25346869408
- McDowellMAFryarCDOgdenCLFlegalKMNational Health Statistics ReportsAnthropometric reference data for children and adults: United States 2003–20062008 Available from: http://www.cdc.gov/nchs/data/nhsr/nhsr010.pdfAccessed June 25, 2014
- MarmorMFEfficient and effective screening for hydroxychloroquine toxicityAm J Ophthalmol2013155341341423394729
- BrowningDJReply to Impact of the revised American Academy of Ophthalmology guidelines regarding hydroxychloroquine screening on actual practiceAm J Ophthalmol2013156241041123870364
- BrowningDJHydroxychloroquine and Chloroquine RetinopathyFirst editionNew YorkSpringer2014